Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
about
Primary biliary cirrhosis and the nuclear pore complex.Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis.Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis.Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patientsAutoantigens in primary biliary cirrhosisAntinuclear antibodies as ancillary markers in primary biliary cirrhosis.Tracing environmental markers of autoimmunity: introducing the infectome.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies.Popular and unpopular infectious agents linked to primary biliary cirrhosis.Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosisEpstein-barr virus as a trigger of autoimmune liver diseases.Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence?Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature.Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisTRAF1-C5 affects quality of life in patients with primary biliary cirrhosisDiagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review.The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significancePotential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New?Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesLong-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.Diagnostic autoantibodies for autoimmune liver diseases.Molecular diagnostics of primary biliary cirrhosis.Clinicopathological significance of serum fractalkine in primary biliary cirrhosis.Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent.Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease.Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).Guidelines for the management of primary biliary cirrhosis
P2860
Q30415170-A52D2566-9FBA-4254-B2AB-667BB52A3CE4Q33751665-4FAAED9C-6B39-4D9A-AFD8-68F0F7961846Q33882608-086CF1D4-5D2A-48C2-BBD0-A97B6D1D0B32Q33912324-5B214125-5E26-49FD-8563-FC66D04A479AQ34111559-68AA6C38-B7E8-4681-AD11-45CB2030BA3BQ34237440-2DD0E3AD-3AAF-4FBE-926C-30D9B8A5C26AQ34671373-77EE973A-137E-484E-88BB-4B2C747D5F26Q35309080-E497F0F1-C929-4A6E-8966-D48BADB3285AQ35309854-CC505556-E625-44D0-9FCB-835E53E73B1CQ35309882-03F8EF91-6973-42FD-84F7-3F857BE51574Q35597275-D3D22CD0-8351-4D41-AD5D-DA7856DF47A5Q36010920-F7C68F00-A20A-497B-9FB9-E04EC66281C9Q36369284-9275A0AC-AD21-4B74-A638-520D8446BEE1Q36417949-7E09BC62-95FF-498C-83C6-63C20A88E343Q36752084-2EC66838-9F67-467E-88C0-EE07605E7FD0Q36848255-23EEAD03-DCE6-4887-B564-AA80AC257B29Q36986983-088F017A-5E24-4C25-B097-03975BC9F0F3Q37388844-013BCA5F-7CEC-447E-A228-965C34282CB8Q37629685-9107C715-3492-4CB4-AF82-7C7F0C65E29CQ38063171-301D302F-76D5-4C53-BAD9-A982AC6C5884Q38543052-E6D84399-C3A9-4869-888A-1CF88039F73EQ38699595-A061E295-8B82-4A69-BCAF-193C348A6157Q39424761-FFAFA751-60CF-43AD-AE5B-49E2908F7A7CQ40086159-C3528494-822A-4888-890F-B58466EB3B48Q45916689-DAED37AC-D42F-40B6-8EA1-263A0C089591Q46067776-C205C077-8CAD-41F7-8C78-198F9319DD96Q50897757-E38BFA49-9FF8-4F24-9BD5-8EB74C462DF2Q52648759-896F70EC-E18E-4230-A2AA-09769CFEF5C8Q56429943-6E6849C7-8FF9-49DF-AA3B-66A480B6818B
P2860
Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@ast
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@en
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@nl
type
label
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@ast
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@en
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@nl
prefLabel
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@ast
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@en
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@nl
P2093
P1476
Autoantibodies against a 210 k ...... ith primary biliary cirrhosis.
@en
P2093
Hayakawa A
Ishihara K
Tashiro-Itoh T
P304
P356
10.1111/J.1440-1746.1998.01553.X
P577
1998-03-01T00:00:00Z